BX
Next earnings: Jul 23, 2026 · Before open
Signal
Leaning Bullish1
Price
1
Move-0.30%Quiet session
Volume
1
Volume0.7× avgNormal activity
Technical
1
RSIRSI 51Momentum positive
PRICE
Prev Close
123.09
Open
123.55
Day Range121.18 – 125.18
121.18
125.18
52W Range101.73 – 190.09
101.73
190.09
24% of range
VOLUME & SIZE
Avg Volume
6.2M
FUNDAMENTALS
P/E Ratio
31.5x
EPS (TTM)
Div Yield
0.05%
Beta
1.70
High vol
Performance
1D
-0.30%
5D
+1.92%
1M
+9.34%
3M
-3.24%
6M
-14.97%
YTD
-20.38%
1Y
-9.84%
Best: 1M (+9.34%)Worst: YTD (-20.38%)
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
revenue +34% YoY · 88% gross margin
Valuation
EXPENSIVE
P/E 31x vs ~20x sector
Health
MODERATE
CR 0.0 (low) · FCF $4.44/sh
Bullish
Key MetricsTTM
Market Cap$226.05B
Revenue TTM$14.99B
Net Income TTM$3.05B
Free Cash Flow$3.48B
Gross Margin87.5%
Net Margin20.4%
Operating Margin48.8%
Return on Equity36.2%
Return on Assets6.3%
Debt / Equity1.69
Current Ratio0.00
EPS TTM$3.90
Alpha SignalsFull Analysis →
What Moves This Stock

Fundraising momentum and AUM growth - new fund commitments drive multi-year fee streams

Deployment pace and dry powder utilization - affects near-term management fee growth and future performance fee potential

Realization activity and performance fee generation - crystallization of carried interest from exits drives earnings volatility

BREIT and BCRED flows - perpetual capital vehicles provide stable, growing fee base with daily/monthly liquidity

Macro Sensitivity
Economic Cycle

high - Deal activity, exit opportunities, and portfolio company performance are highly correlated with GDP growth and business confidence. Economic expansions drive M&A volumes, IPO markets, and asset appreciation enabling realizations. Recessions compress entry/exit multiples and reduce deployment opportunities, though counter-cyclically create distressed credit opportunities.

Interest Rates

Rising rates create mixed effects: (1) Negative for asset valuations - higher discount rates compress private equity and real estate portfolio marks, reducing unrealized performance fees and making exits more challenging; (2) Negative for fundraising - institutional investors face denominator effect as public equity allocations decline, forcing alternative allocation reductions; (3) Positive for credit strategies - BCRED and opportunistic credit earn higher yields on new deployments; (4) Negative for leverage costs - increases financing expenses for portfolio companies and deal economics. Net impact is moderately negative in rising rate environments.

Key Risks

Fee compression from passive alternatives and direct co-investment - institutional LPs increasingly negotiate lower management fees (1.25% vs 1.5%) and reduced carry (15-17.5% vs 20%) or bypass managers entirely for mega-deals

Regulatory scrutiny on fee structures and conflicts - SEC focus on monitoring fees, allocation practices, and accelerated fee provisions could compress economics

Denominator effect during equity bear markets - when public equity values decline, institutional investors become over-allocated to alternatives and must reduce commitments to rebalance

Investor Profile

growth - Investors focus on 15-20% AUM CAGR potential, operating leverage from fee margin expansion, and long-term wealth compounding through performance fees. The stock attracts growth-at-reasonable-price investors given premium valuation (17.3x P/S) justified by asset-light model, 36% ROE, and secular tailwinds from institutional allocation shifts to alternatives. Dividend yield of 2-3% provides income component but total return driven by earnings growth.

Watch on Earnings
Fee-related earnings (FRE) growth rate and margin expansionTotal AUM and net inflows by segment (PE, RE, Credit, HFSS)BREIT monthly flows and net asset value performanceDry powder deployment rate and capital overhang
Health Radar
2 strong2 watch2 concern
51/100
Liquidity
0.00Concern
Leverage
1.69Watch
Coverage
13.9xStrong
ROE
36.2%Strong
ROIC
12.9%Watch
Cash
$2.6BConcern
ANALYST COVERAGE20 analysts
HOLD
+27.1%upside to target
L $130.00
Med $156.00consensus
H $184.00
Buy
1050%
Hold
945%
Sell
15%
10 Buy (50%)9 Hold (45%)1 Sell (5%)
Full report →
Stock Health
Composite Score
3 of 5 signals bullish
8/10
Technicals
RSI RangeRSI 51 — Bullish momentum
Volume
Volume FlowAccumulation — institutional buying
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusHold
~
LiquidityCurrent Ratio 0.00 — liquidity risk
Upcoming Events
EEarnings Report · After CloseMay 7, 2026
Tomorrow
DEx-Dividend DateAug 4, 2026
In 90 days
PDividend PaymentSep 1, 2026
In 118 days
Technicals
Technical SetupBULLISH
Technicals →

Trend

RallyDeath Cross · 50D trails 200D by 20.7%

+5.1% vs SMA 50 · -16.7% vs SMA 200

Momentum

RSI51.0
Neutral territory
MACD+1.66
Above zero — bullish momentum · compressing
Market Position
Price Levels
52W High
$190.1+54.9%
EMA 200
$139.9+14.0%
Current
$122.7
EMA 50
$122.7-0.0%
52W Low
$101.7-17.1%
52-Week RangeNear 52-week low
$101.724th %ile$190.1
Squeeze SetupVolume-based
Moderate Squeeze Setup

Accumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.

20-Day Money Flow
Acc days:9
Dist days:5
Edge:+4 acc
Volume Context
Avg Vol (50D)3.7M
Recent Vol (5D)
4.3M+17%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 14 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2024
$11.4B
$11.2B$11.6B
$4.42
±1%
High14
FY2025
$12.7B
$12.5B$12.9B
+11.7%$5.36+21.1%
±1%
High14
FY2026(current)
$14.9B
$14.2B$16.0B
+16.9%$5.97+11.4%
±5%
High14
Range confidence:Tight (high)ModerateWide (low)
🔥Beat 7 consecutive quarters
Earnings HistoryBX
Last 8Q
+9.3%avg beat
Beat 7 of 8 quartersMissed 1 Estimates rising
-2%
Q3'24
+10%
Q4'24
+14%
Q1'25
+4%
Q2'25
+10%
Q3'25
+24%
Q4'25
+14%
Q1'26
+1%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →
No recent activity
UBSNeutral → Buy
Dec 11
UPGRADE
Wolfe ResearchOutperform
Dec 10
UPGRADE
GuggenheimNeutral
Nov 11
DOWNGRADE
BTIGPerform
Oct 15
UPGRADE
Piper SandlerOverweight → Neutral
Oct 9
DOWNGRADE
UBSNeutral
Apr 2
DOWNGRADE
OppenheimerOutperform
Apr 13
UPGRADE
Wells FargoEqual-Weight → Overweight
Jan 11
UPGRADE
Insider Activity
SEC Filings →
4 Buys/2 SellsNet Buying
NET SELLERS$0 bought · $3.8M sold · 30d window
Sawhney VikrantChief Administ…
$2.1M
May 1
SELL
Sawhney VikrantChief Administ…
$1.6M
May 1
SELL
Porat RuthDir
$36K
Feb 17
BUY
Porat RuthDir
$20K
Feb 17
BUY
Porat RuthDir
$13K
Feb 17
BUY
Porat RuthDir
$31K
Nov 10
BUY
Financials
Dividends4.05% yield
+21.9% avg annual growth
Annual Yield4.05%
Quarterly Div.$1.1600
Est. Annual / Share$4.64
FrequencyQuarterly
Q3'24
Q4'24
Q1'25
Q2'25
Q3'25
Q4'25
Q1'26
Q2'26

Dividend per payment — last 8 periods

INSTITUTIONAL OWNERSHIP

1
Nuveen, LLC
2.0M
2
HSBC HOLDINGS PLC
1.7M
3
Sumitomo Mitsui Trust Holdings, Inc.
1.6M
4
MARKEL GROUP INC.
1.2M
5
abrdn plc
1.0M
6
PRINCIPAL FINANCIAL GROUP INC
859K
7
Janney Montgomery Scott LLC
760K
8
Advisors Capital Management, LLC
711K
News & Activity

BX News

20 articles · 4h ago

About

blackstone is the world’s largest alternative asset manager. we seek to create positive economic impact and long-term value for our investors, the companies we invest in, and the communities in which we work. we do this by using extraordinary people and flexible capital to help companies solve problems. our $731 billion in assets under management include investment vehicles focused on private equity, real estate, public debt and equity, infrastructure, life sciences, growth equity, opportunistic, non-investment grade credit, real assets and secondary funds, all on a global basis. further information is available at www.blackstone.com. follow blackstone on twitter @blackstone.

CEO
Stephen A. Schwarzman
PeersFinancial Services(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
BX
$122.72-0.30%$147.4B31.5+2158.1%2183.3%1495
$309.40+0.57%$834.5B14.6+330.7%2039.3%1505
$322.03-1.47%$617.3B27.7+1134.0%5014.5%1499
$497.08-1.52%$440.0B28.4+1641.6%4564.7%1489
$53.12+1.78%$377.0B12.2-45.1%1592.6%1503
$189.25+0.64%$300.4B16.3+1147.7%1466.4%1518
$918.89+1.73%$272.7B15.5-138.4%1373.0%1516
Sector avg+0.20%20.9+889.8%2604.8%1504